Oncology Biologics and Monoclonal Antibody Expert Witness

This expert is a dual-doctorate (M.D., Ph.D.) physician-scientist, board certified in clinical pharmacology, with a 40 year career in oncology drug development including vice president level clinical development leadership at biopharmaceutical companies and faculty appointments at two major research universities.

Expertise spans oncology clinical pharmacology, monoclonal antibody biologics and biosimilars, platinum chemotherapy agents and their toxicities, pharmacokinetics and pharmacodynamics, and Phase I through III oncology trial design. This expert has been retained in at least nine international biologics and oncology patent disputes since 2013, producing expert reports, sitting for depositions, and testifying at trial.

Attorneys retain this expert for biologics and biosimilar patent litigation, pharmaceutical product liability involving cancer therapeutics, and matters turning on clinical trial design and regulatory review.